Exponent (EXPO) Expected to Announce Quarterly Earnings on Thursday

Exponent (NASDAQ:EXPOGet Free Report) is expected to release its Q3 2025 results after the market closes on Thursday, October 30th. Analysts expect Exponent to post earnings of $0.50 per share and revenue of $131.7790 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Thursday, October 30, 2025 at 4:30 PM ET.

Exponent (NASDAQ:EXPOGet Free Report) last announced its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.04. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The business had revenue of $132.87 million for the quarter, compared to analyst estimates of $130.82 million. During the same quarter in the previous year, the firm posted $0.57 earnings per share. Exponent’s revenue was up 7.3% compared to the same quarter last year. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Exponent Price Performance

EXPO opened at $67.77 on Tuesday. Exponent has a fifty-two week low of $63.81 and a fifty-two week high of $112.75. The firm’s fifty day moving average price is $69.41 and its two-hundred day moving average price is $73.37. The company has a market capitalization of $3.42 billion, a P/E ratio of 33.89 and a beta of 0.91.

Insider Activity at Exponent

In other Exponent news, CEO Catherine Corrigan sold 4,930 shares of the company’s stock in a transaction that occurred on Wednesday, October 15th. The stock was sold at an average price of $66.82, for a total transaction of $329,422.60. Following the completion of the transaction, the chief executive officer owned 82,753 shares of the company’s stock, valued at $5,529,555.46. This represents a 5.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Joseph Sala sold 1,595 shares of the company’s stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total value of $112,670.80. The disclosure for this sale can be found here. Insiders sold a total of 16,326 shares of company stock valued at $1,133,059 over the last quarter. 1.60% of the stock is owned by insiders.

Institutional Investors Weigh In On Exponent

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Osaic Holdings Inc. raised its stake in Exponent by 3.8% in the 2nd quarter. Osaic Holdings Inc. now owns 6,362 shares of the business services provider’s stock valued at $476,000 after acquiring an additional 234 shares during the period. Orion Porfolio Solutions LLC raised its stake in Exponent by 2.6% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 8,525 shares of the business services provider’s stock valued at $637,000 after acquiring an additional 219 shares during the period. FORA Capital LLC bought a new stake in Exponent in the 2nd quarter valued at $228,000. CANADA LIFE ASSURANCE Co raised its stake in Exponent by 3.2% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 37,822 shares of the business services provider’s stock valued at $2,827,000 after acquiring an additional 1,188 shares during the period. Finally, Tower Research Capital LLC TRC raised its stake in Exponent by 149.2% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,537 shares of the business services provider’s stock valued at $414,000 after acquiring an additional 3,315 shares during the period. Institutional investors own 92.37% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold”.

Check Out Our Latest Report on EXPO

About Exponent

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Earnings History for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.